These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 210616)

  • 1. Progression of a structural scoliosis during treatment with growth hormone. A case report.
    Dymling JF; Willner S
    Acta Orthop Scand; 1978 Jun; 49(3):264-8. PubMed ID: 210616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adult height exceeding target height in a patient with congenital panhypopituitarism diagnosed after the age of 25 years.
    Arrigo T; Crisafulli G; Salamone A; Cucinotta D; De Luca F
    J Pediatr Endocrinol; 1994; 7(3):269-72. PubMed ID: 7820223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone and sex steroid stimulated growth at puberty.
    Nutr Rev; 1977 Oct; 35(10):268-71. PubMed ID: 199863
    [No Abstract]   [Full Text] [Related]  

  • 4. Reversible hypothyroidism in growth hormone-deficient children treated with human growth hormone.
    Lippe BM; Van Herle AJ; LaFranchi SH; Uller RP; Lavin N; Kaplan SA
    J Clin Endocrinol Metab; 1975 Apr; 40(4):612-8. PubMed ID: 165211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative importance of growth hormone and sex steroids for the growth at puberty of trunk length, limb length, and muscle width in growth hormone-deficient children.
    Tanner JM; Whitehouse RH; Hughes PC; Carter BS
    J Pediatr; 1976 Dec; 89(6):1000-8. PubMed ID: 993900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth of males with idiopathic hypopituitarism without growth hormone treatment.
    van der Werff ten Bosch JJ; Bot A
    Clin Endocrinol (Oxf); 1990 Jun; 32(6):707-17. PubMed ID: 2383924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth increments with low dose intermittent growth hormone and fluoxymesterone in first year of therapy in hypopituitarism.
    Kirkland RT; Clayton GW
    Pediatrics; 1979 Mar; 63(3):386-8. PubMed ID: 220585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of scoliosis in six children treated with growth hormone.
    Vidil A; Journeau P; Soulie A; Padovani JP; Pouliquen JC
    J Pediatr Orthop B; 2001 Jul; 10(3):197-200. PubMed ID: 11497361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical Research Council of Canada therapeutic trial of human growth hormone: first 5 years of therapy.
    Guyda H; Friesen H; Bailey JD; Leboeuf G; Beck JC
    Can Med Assoc J; 1975 Jun; 112(11):1301-9. PubMed ID: 165002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collaborative study of the effects of human growth hormone in growth hormone deficiency. I. First year of therapy.
    Aceto T; Frasier SD; Hayles AB; Meyer-Bahlburg HF; Parker ML; Munschauer R; Di Chiro G
    J Clin Endocrinol Metab; 1972 Oct; 35(4):483-96. PubMed ID: 5052971
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term follow-up of childhood-onset hypopituitarism in patients with the PROP-1 gene mutation.
    Pavel ME; Hensen J; Pfäffle R; Hahn EG; Dörr HG
    Horm Res; 2003; 60(4):168-73. PubMed ID: 14530604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of hypopituitarism with recombinant somatropin for 1 year.
    Takano K; Shizume K; Hibi I; Okuno A; Hanyu K; Suwa S; Nakajima H; Kondo T; Kato K; Iwatani N
    Acta Paediatr Scand Suppl; 1988; 347():169-75. PubMed ID: 3254031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxandrolone and human growth hormone. Comparison of growth-stimulating effects in short children.
    Raiti S; Trias E; Levitsky L; Grossman MS
    Am J Dis Child; 1973 Nov; 126(5):597-600. PubMed ID: 4355445
    [No Abstract]   [Full Text] [Related]  

  • 14. Hormone-replacement Therapy for Hepatopulmonary Syndrome and NASH Associated with Hypopituitarism.
    Torii N; Ichihara A; Mizuguchi Y; Seki Y; Hashimoto E; Tokushige K
    Intern Med; 2018; 57(12):1741-1745. PubMed ID: 29910217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone treatment for short stature.
    Van Vliet G; Styne DM; Kaplan SL; Grumbach MM
    N Engl J Med; 1983 Oct; 309(17):1016-22. PubMed ID: 6684729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of growth and of endocrine systems in testosterone-corticosteroid-treated patients with aplastic anemia.
    Shahidi NT; Crigler JF
    J Pediatr; 1967 Feb; 70(2):233-42. PubMed ID: 4289449
    [No Abstract]   [Full Text] [Related]  

  • 17. Endocrine function in thalassemia major.
    Kuo B; Zaino E; Roginsky MS
    J Clin Endocrinol Metab; 1968 Jun; 28(6):805-8. PubMed ID: 4297791
    [No Abstract]   [Full Text] [Related]  

  • 18. Response to growth hormone therapy in adolescents with familial panhypopituitarism.
    Kulshreshtha B; Eunice M; Ammini AC
    Indian Pediatr; 2010 Apr; 47(4):356-8. PubMed ID: 20431169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The primary empty sella an endocrine study on 12 cases.
    Schaison G; Metzger J
    Acta Endocrinol (Copenh); 1976 Nov; 83(3):483-92. PubMed ID: 989992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypopituitarism.
    Rogol AD
    Curr Ther Endocrinol Metab; 1994; 5():26-9. PubMed ID: 7704728
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.